DUBLIN /PRNewswire/ -- The "Global Autoinjectors Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The global autoinjectors market to grow at a CAGR of 23.50% during the period 2019-2023.

Global Autoinjectors Market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one driver in the market is increasing prevalence of allergies and need for immediate care. Globally, the prevalence of allergies to food items, pollens, food additives, latex, and dust and the risk of contracting anaphylaxis caused by these factors are increasing. According to CDC, allergies are the sixth leading cause of chronic illness in the US with an annual expenditure of more than S18 billion.

One trend in the market is growing popularity of injectable therapies. Injectable therapies account for a significant share of the global drug market. Factors boosting the growth of the market are high-value biologics, such as monoclonal antibodies and peptides, which require injection due to their size and sensitivity Injection-based drug delivery targets areas such as immuno-oncology, diabetes, and auto-immune diseases.

Further, the report states that one challenge in the market is side-effects of autoinjectors. The use of autoinjectors cause several side-effects, such as infection, hypertension, hypotension, myalgia, headache, and diarrhea Patients with chemotherapy-induced anemia exhibit fatigue, edema, nausea, vomiting, fever, and increased occurrence of hypertension.

Key questions answered in this report

  • What will the market size be in 2023 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

Key vendors

  • Amgen
  • Bayer
  • BD
  • Eli Lilly
  • Novartis

Key Topics Covered: 

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

  • Market segmentation by application
  • Comparison by application
  • Anaphylaxis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Others
  • Market opportunity by application

PART 07: SEGMENTATION BY END-USER

  • Segmentation by end-user

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors

For more information about this report visit https://www.researchandmarkets.com/research/wvc8rp/global?w=5


Media Contact:

Laura Wood, Senior Manager 
press@researchandmarkets.com 

For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630 
For GMT Office Hours Call +353-1-416-8900 

U.S. Fax: 646-607-1907 
Fax (outside U.S.): +353-1-481-1716